Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: An analysis of data from the National Ambulatory Medical Care Survey for 1996-2001

Clinical Therapeutics

Volumn 27, Issue 12, 2005, Pages 1970-1979

  Rasu, Rafia S ^a   Shenolikar, Rahul A ^b   Nahata, Milap C ^b   Balkrishnan, Rajesh ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Ambulatory care; Costs; Drug therapy; Sleep initiation maintenance disorders; Therapy; United States

Indexed keywords

CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; ESTAZOLAM; FLURAZEPAM; LORAZEPAM; OXAZEPAM; QUAZEPAM; TEMAZEPAM; TRIAZOLAM; ZALEPLON; ZOLPIDEM TARTRATE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG ABUSE; DRUG COST; DRUG DEPENDENCE; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HISPANIC; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MENTAL DISEASE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT; OUTPATIENT CARE; PHYSICIAN; PRESCRIPTION; SEX DIFFERENCE; SLEEP DISORDER; SOCIOECONOMICS; STATISTICAL ANALYSIS; TABLET; UNITED STATES; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMBULATORY CARE; ANTI-ANXIETY AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HISPANIC AMERICANS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OWNERSHIP; PRACTICE MANAGEMENT, MEDICAL; SEX FACTORS; SLEEP DISORDERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33644542730     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.12.008     Document Type: Article

References (47)

1. Katz D.A., and McHorney C.A. The relationship between insomnia and health-related quality of life in patients with chronic illness J Fam Pract. 51 2002 229 235
2. Simon G.E., and VonKorff M. Prevalence, burden, and treatment of insomnia in primary care Am J Psychiatry 154 1997 1417 1423
3. Smith M.T., and Neubauer D.N. Cognitive behavior therapy for chronic insomnia Clin Cornerstone 5 2003 28 40
4. Roth T., and Roehrs T. Insomnia: Epidemiology, characteristics, and consequences Clin Cornerstone 5 2003 5 15
5. Ancoli-Israel S., and Roth T. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. I Sleep 22 Suppl 2 1999 5347 5353
6. Drake C.L., Roehrs T., and Roth T. Insomnia causes, consequences, and therapeutics: An overview Depress Anxiety 18 2003 163 176
7. Available at: National Sleep Foundation Accessed January 25, 2004 Sleep in America poll 2002
8. Kapur V.K., Redline S., Nieto F.J. Sleep Heart Health Research Group The relationship between chronically disrupted sleep and healthcare use Sleep 25 2002 289 296
9. Hatoum H.T., Kong S.X., and Kania C.M. Insomnia, healthrelated quality of life and healthcare resource consumption. A study of managed-care organisation enrollees PharmacoEconomics 14 1998 629 637
10. Rajput V., and Bromley S.M. Chronic insomnia: A practical review Am Fam Physician 60 1999 1431 1438
11. Walsh J.K., and Engelhardt C.L. The direct economic costs of insomnia in the United States for 1995 Sleep 22 Suppl 2 1999 5386 5393
12. Eisenberg J.M. Sociologic influences on decision-making by clinicians Ann Intern Med. 90 1979 957 964
13. Fraser A.D. Use and abuse of the benzodiazepines Ther Drug Monit. 20 1998 481 489
14. Schweizer E., and Rickels K. Benzodiazepine dependence and withdrawal: A review of the syndrome and its clinical management Acta Psychiatr Scand Suppl. 393 1998 95 101
15. Longo L.P., Parran T. Jr, Johnson B., and Kinsey W. Addiction: Part II. Identification and management of the drug-seeking patient Am Fam Physician. 61 2000 2401 2408
16. Lippmann S., Mazour I., and Shahab H. Insomnia: Therapeutic approach South Med J. 94 2001 866 873
17. Vermeeren A. Residual effects of hypnotics: Epidemiology and clinical implications CNS Drugs 18 2004 297 328
18. Lader M. Zopiclone: Is there any dependence and abuse potential? J Neurol. 244 Suppl 1 1997 518 522
19. Rush C.R. Behavioral pharmacology of zolpidem relative to benzodiazepines: A review Pharmacol Biochem Behav. 61 1998 253 269
20. Darcourt G., Pringuey D., and Salliere D. The safety and tolerability of zolpidem-an update J Psychopharmacol 13 1999 81 93
21. Hajak G. A comparative assessment of the risks and benefits of zopiclone: A review of 15 years' clinical experience Drug Saf. 21 1999 457 469
22. Soyka M., Bottlender R., and Moller H.J. Epidemiological evidence for a low abuse potential of zolpidem Pharmacopsychiatry 33 2000 138 141
23. Neubauer D.N. Pharmacologic approaches for the treatment of chronic insomnia Clin Cornerstone 5 2003 16 27
24. Hajak G., Muller W.E., and Wittchen H.U. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: A review of case reports and epidemiological data Addiction 98 2003 1371 1378
25. Wagner J., and Wagner M.L. Non-benzodiazepinesforthetreatment of insomnia Sleep Med Rev. 4 2000 551 581
26. Terzano M.G., Rossi M., and Palomba V. New drugs for insomnia: Comparative tolerability of zopiclone, zolpidem and zaleplon Drug Saf 26 2003 261 282
27. Smith M.T., Perlis M.L., and Park A. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia Am J Psychiatry 159 2002 5 11
28. Available at: National Center for Health Statistics Ambulatory health care data. NAMCS description Accessed February 16, 2004
29. Drug Topics Red Book 2003 Medical Economics Data Montvale, NJ
30. Hosmer D.W. Jr Lemeshow S. Applied Logistic Regression 2nd ed 2000 John Wiley & Sons New York
31. Culpepper L. Generalized anxiety disorder in primary care: Emerging issues in management and treatment J Clin Psychiatry 63 Suppl 8 2002 35 42
32. Jindal R.D., Buysse D.J., and Thase M.E. Maintenance treatment of insomnia: What can we learn from the depres sion literature? Am J Psychiatry 161 2004 19 24
33. McClusky H.Y., Milby J.B., and Switzer P.K. Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia Am J Psychiatry 148 1991 121 126
34. Morin C.M., Colecchi C., and Stone J. Behavioral and pharmacological therapies for late-life insomnia: A randomized controlled trial JAMA 281 1999 991 999
35. Ochs H.R., Greenblatt D.J., and Divoll M. Diazepam kinetics in relation to age and sex Pharmacology 23 1981 24 30
36. Divoll M., Greenblatt D.J., Harmatz J.S., and Shader R.I. Effect of age and gender on disposition of temazepam J Pharm Sci. 70 1981 1104 1107
37. Tran C., Knowles S.R., Liu B.A., and Shear N.H. Gender differences in adverse drug reactions J Clin Pharmacol 38 1998 1003 1009
38. Martin R.M., Biswas P.N., and Freemantle S.N. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: Analysis of 48 cohort studies Br J Clin Pharmacol 46 1998 505 511
39. Figueras A., Capella D., Castel J.M., and Laorte J.R. Spontaneous reporting of adverse drug reactions to non steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and entericcoated formulations Eur J Clin Pharmacol 47 1994 297 303
40. Sihvo S., Klaukka T., Martikainen J., and Hemminki E. Frequency of daily over-the-counter drug use and po tential clinically significant over-thecounter-prescription drug interactions in the Finnish adult population Eur J Clin Pharmacol 56 2000 495 499
41. Al-Windi A., Elmfeldt D., and Svardsudd K. The relationship between age, gender, wellbeing and symptoms, and the use of pharmaceuticals, herbal medicines and self-care products in a Swedish municipality Eur J Clin Pharmacol 56 2000 311 317
42. Daumit G.L., Crum R.M., and Guallar E. Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States Arch Gen Psychiatry 60 2003 121 128
43. Briesacher B., Limcangco R., and Gaskin D. Racial and ethnic disparities in prescription coverage and medica tion usage Health Care Financ Rev. 25 2003 63 76
44. Schore J., Brown R., and Lavin B. Racial disparities in prescription drug use among dually eligible beneficiaries Health Care Financ Rev. 25 2003 77 90
45. Balkrishnan R., Cook J.M., and Shaffer M.P. Analysis of factors associated with prescription of a poten tially inappropriate combination dermatological medication among US outpatient physicians Pharmacoepidemiol Drug Saf. 13 2004 133 138
46. Balkrishnan R., Rasu R.S., and Rajagopalan R. Physician and patient determinants of the pharmacologic treat ment of sleep difficulties in outpatient settings in the United States Sleep 28 2005 715 719
47. Clark J.A., Potter D.A., and McKinlay J.B. Bringing social structure back into clinical decision making Soc Sci Med. 32 1991 853 866